Instead of gene fusions, a small subset of these tumors in soft tissues or kidneys (in the latter site a traditional name congenital mesoblastic nephroma is often used) may harbor activating EGFR or BRAF point mutations [8–12]. Here, EGFR is linked to congenital mesoblastic nephroma.